Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors
- DOI
- 10.21037/tcr-2026-1700
- Published
- 2026-10
- Container
- Translational Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tcr-2026-1700,
title = {Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors},
author = {Hailin Zhang and Qiao Li and Xuan Yao and Bo Wang and Yawen Pan and Guoqiang Yuan},
year = {2026},
journal = {Translational Cancer Research},
doi = {10.21037/tcr-2026-1700},
url = {https://doi.org/10.21037/tcr-2026-1700}
}RIS
TY - JOUR TI - Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors AU - Hailin Zhang AU - Qiao Li AU - Xuan Yao AU - Bo Wang AU - Yawen Pan AU - Guoqiang Yuan PY - 2026 JO - Translational Cancer Research DO - 10.21037/tcr-2026-1700 UR - https://doi.org/10.21037/tcr-2026-1700 ER -
APA
Zhang, H., Li, Q., Yao, X., Wang, B., Pan, Y., & Yuan, G. (2026). Inhibition of malignant progression in mesenchymal glioblastoma by PARP1 inhibitors. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-1700
Source records
- crossref · retrieved 2026-11-10T12:49:50.397Z